Pipeline

Emergent’s approach is to achieve balance in the products that we develop through a pipeline comprising innovative vaccines and therapeutics that target diseases worldwide.

Program

Pre Clinical
Phase 1
Phase 2
Phase 3

UniFlu

(Universal influenza vaccine)

Pre Clinical
Phase 1
Phase 2
Phase 3
Phase 4

WEVEE VLP

(Western, Eastern and Venezuelan equine encephalitic VLP)

Pre Clinical
Phase 1
Phase 2
Phase 3
Phase 4

Pan-Ebola mAb

(Ebola/Sudan monoclonal)

Pre Clinical
Phase 1
Phase 2
Phase 3
Phase 4

Expanded Access Policy

LEARN MORE

This website uses cookies. This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Notice and Terms of Use.